NCT04738331

Brief Summary

Analysing ths spread of COVID-19 epidemics in a timely manner is key to implementing public health control strategies. The investigators propose to analyse a large set of laboratory SARS-CoV-2 RT-PCR data to explore potential links between Ct values and epidemic parameters.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
10,000,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Feb 2021

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 1, 2021

Completed
1 day until next milestone

First Submitted

Initial submission to the registry

February 2, 2021

Completed
2 days until next milestone

First Posted

Study publicly available on registry

February 4, 2021

Completed
1.3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 20, 2022

Completed
1 month until next milestone

Study Completion

Last participant's last visit for all outcomes

June 30, 2022

Completed
Last Updated

May 26, 2021

Status Verified

May 1, 2021

Enrollment Period

1.3 years

First QC Date

February 2, 2021

Last Update Submit

May 25, 2021

Conditions

Covid-19SARS-CoV Infection

Keywords

SARS-Cov2 infectionTested for SARS-Cov2 infection with RT-PCR testCTepidemiologyreproduction number

Outcome Measures

Primary Outcomes (1)

  • Detecting co-factors associated with Ct values

    Detecting co-factors associated with Ct values

    1 day

Secondary Outcomes (1)

  • Detecting associations with epidemic spread

    1 day

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

French population with a RT-PCR test for SARS-Cov2 infection

You may qualify if:

  • \- A SARS-Cov2 RT-PCR result with a known sampling date

You may not qualify if:

  • \- Patient refusing to participate in research

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Uh Montpellier

Montpellier, 34295, France

RECRUITING

MeSH Terms

Conditions

COVID-19Severe Acute Respiratory Syndrome

Condition Hierarchy (Ancestors)

Pneumonia, ViralPneumoniaRespiratory Tract InfectionsInfectionsVirus DiseasesCoronavirus InfectionsCoronaviridae InfectionsNidovirales InfectionsRNA Virus InfectionsLung DiseasesRespiratory Tract Diseases

Study Officials

  • Vincent Foulongne, PhD

    UH MONTPELLIER

    STUDY DIRECTOR

Central Study Contacts

Samuel Alizon, PhD

CONTACT

610654902samuel.alizon@cnrs.fr

Vincent Foulongne, PhD

CONTACT

467 330 254v-foulongne@chu-montpellier.fr

Study Design

Study Type
observational
Observational Model
OTHER
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 2, 2021

First Posted

February 4, 2021

Study Start

February 1, 2021

Primary Completion

May 20, 2022

Study Completion

June 30, 2022

Last Updated

May 26, 2021

Record last verified: 2021-05

Locations

FR(1)